Literature DB >> 9316955

Recovery and kinetic characteristics of desflurane and sevoflurane in volunteers after 8-h exposure, including kinetics of degradation products.

E I Eger1, T Bowland, P Ionescu, M J Laster, Z Fang, D Gong, J Sonner, R B Weiskopf.   

Abstract

BACKGROUND: Desflurane and sevoflurane permit speedier changes in anesthetic partial pressures than do older halogenated anesthetics. The authors determined the kinetic characteristics of desflurane and sevoflurane and those of compound A [CH2F-O-C(=CF2)(CF3)], a nephrotoxic degradation product of sevoflurane.
METHODS: Volunteers received 1.25 minimum alveolar concentration of desflurane or sevoflurane, each administered for 8 h in a fresh gas inflow of 2 l/min. Inspired (F(I)) and end-tidal (F(A)) concentrations of anesthetic and compound A were measured during administration, and F(A) relative to F(A0) (the last end-tidal concentration during administration) during elimination. The indices of recovery were also measured.
RESULTS: The ratio F(I)/F(A) rapidly approached 1.0, with values greater for sevoflurane (desflurane 1.06 +/- 0.01 vs. sevoflurane 1.11 +/- 0.02, mean +/- SD). The ratio F(A)/F(I) for compound A was approximately 0.8. The F(A)/F(A0) ratio decreased slightly more rapidly with desflurane than with sevoflurane, and objective measures indicated faster recovery with desflurane: The initial response to command (14 +/- 4 min vs. 28 +/- 8 min [means +/- SD]) and orientation (19 +/- 4 vs. 33 +/- 9 min) was quicker, and recovery was faster as defined by results of the Digit Symbol Substitution, P-deletion, and Trieger tests. Desflurane produced less vomiting (1 [0.5, 3]; median [quartiles] episodes) than did sevoflurane (5 [2.5, 7.5] episodes). The F(A)/F(A0) ratio for compound A decreased within 5 min to a constant value of 0.1.
CONCLUSIONS: These anesthetics have kinetics consistent with their solubilities. Sevoflurane's greater biodegradation probably increases F(I)/F(A) differences during anesthetic administration and decreases F(A)/F(A0) differences during elimination. The F(A) for compound A differs from F(I) by 20% (F(A)/F(I) = 0.8) because of substantial degradation. Recovery from anesthesia proceeds nearly twice as fast with desflurane than with sevoflurane. Differences in ventilation, or alveolar or tissue elimination, do not completely explain the slower recovery with sevoflurane.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9316955     DOI: 10.1097/00000542-199709000-00010

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  10 in total

Review 1.  [Pharmacokinetic-pharmacodynamic models for inhaled anaesthetics].

Authors:  S Kreuer; J Bruhn; W Wilhelm; T Bouillon
Journal:  Anaesthesist       Date:  2007-06       Impact factor: 1.041

2.  Comparative pharmacodynamic modeling of desflurane, sevoflurane and isoflurane.

Authors:  Sascha Kreuer; Jörgen Bruhn; Wolfram Wilhelm; Ulrich Grundmann; Hauke Rensing; Stefan Ziegeler
Journal:  J Clin Monit Comput       Date:  2009-08-27       Impact factor: 2.502

Review 3.  Clinical and economic factors important to anaesthetic choice for day-case surgery.

Authors:  E I Eger; P F White; M S Bogetz
Journal:  Pharmacoeconomics       Date:  2000-03       Impact factor: 4.981

Review 4.  Clinical pharmacokinetics of sevoflurane.

Authors:  M Behne; H J Wilke; S Harder
Journal:  Clin Pharmacokinet       Date:  1999-01       Impact factor: 6.447

5.  Preoperative Sedative-hypnotic Medication Use and Adverse Postoperative Outcomes.

Authors:  Timothy G Gaulton; Hannah Wunsch; Lakisha J Gaskins; Charles E Leonard; Sean Hennessy; Michael Ashburn; Colleen Brensinger; Craig Newcomb; Duminda Wijeysundera; Brian T Bateman; Jennifer Bethell; Mark D Neuman
Journal:  Ann Surg       Date:  2021-08-01       Impact factor: 13.787

6.  Comparison of intraoperative brain condition, hemodynamics and postoperative recovery between desflurane and sevoflurane in patients undergoing supratentorial craniotomy.

Authors:  Surya Kumar Dube; Mihir Prakash Pandia; Arvind Chaturvedi; Parmod Bithal; Hari Hara Dash
Journal:  Saudi J Anaesth       Date:  2015 Apr-Jun

7.  Nephrogenic Diabetes Insipidus following an Off-Label Administration of Sevoflurane for Prolonged Sedation in a COVID-19 Patient and Possible Influence on Aquaporin-2 Renal Expression.

Authors:  Camie Dupuis; Arnaud Robert; Ludovic Gerard; Johann Morelle; Pierre-François Laterre; Philippe Hantson
Journal:  Case Rep Anesthesiol       Date:  2022-03-11

8.  Hemodynamics and early recovery characteristics of desflurane versus sevoflurane in bariatric surgery.

Authors:  Amandeep Kaur; Anil Kumar Jain; Raminder Sehgal; Jayashree Sood
Journal:  J Anaesthesiol Clin Pharmacol       Date:  2013-01

9.  Protocol for the Reconstructing Consciousness and Cognition (ReCCognition) Study.

Authors:  Kaitlyn L Maier; Andrew R McKinstry-Wu; Ben Julian A Palanca; Vijay Tarnal; Stefanie Blain-Moraes; Mathias Basner; Michael S Avidan; George A Mashour; Max B Kelz
Journal:  Front Hum Neurosci       Date:  2017-06-07       Impact factor: 3.473

10.  Risk Factors of Postoperative Vomiting in the Eye of "Real-World Evidence"-Modifiable and Clinical Setting-Dependent Risk Factors in Surgical Trauma Patients.

Authors:  Yan-Yuen Poon; Ting-Yu Ke; Kuo-Chuan Hung; Hsiao-Feng Lu; Min-Hsien Chiang; Jo-Chi Chin; Shao-Chun Wu
Journal:  J Pers Med       Date:  2021-05-08
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.